Cargando…
Patterns of care for prostate cancer radiotherapy—results from a survey among German-speaking radiation oncologists
BACKGROUND: Emerging moderately hypofractionated and ultra-hypofractionated schemes for radiotherapy (RT) of prostate cancer (PC) have resulted in various treatment options. The aim of this survey was to evaluate recent patterns of care of German-speaking radiation oncologists for RT of PC. METHODS:...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547211/ https://www.ncbi.nlm.nih.gov/pubmed/33506347 http://dx.doi.org/10.1007/s00066-020-01738-1 |
_version_ | 1784590337609564160 |
---|---|
author | Vogel, Marco M. E. Dewes, Sabrina Sage, Eva K. Devecka, Michal Gschwend, Jürgen E. Schiller, Kilian Combs, Stephanie E. |
author_facet | Vogel, Marco M. E. Dewes, Sabrina Sage, Eva K. Devecka, Michal Gschwend, Jürgen E. Schiller, Kilian Combs, Stephanie E. |
author_sort | Vogel, Marco M. E. |
collection | PubMed |
description | BACKGROUND: Emerging moderately hypofractionated and ultra-hypofractionated schemes for radiotherapy (RT) of prostate cancer (PC) have resulted in various treatment options. The aim of this survey was to evaluate recent patterns of care of German-speaking radiation oncologists for RT of PC. METHODS: We developed an online survey which we distributed via e‑mail to all registered members of the German Society of Radiation Oncology (DEGRO). The survey was completed by 109 participants between March 3 and April 3, 2020. For evaluation of radiation dose, we used the equivalent dose at fractionation of 2 Gy with α/β = 1.5 Gy, equivalent dose (EQD2 [1.5 Gy]). RESULTS: Median EQD2(1.5 Gy) for definitive RT of the prostate is 77.60 Gy (range: 64.49–84.00) with median single doses (SD) of 2.00 Gy (range: 1.80–3.00), while for postoperative RT of the prostate bed, median EQD2(1.5 Gy) is 66.00 Gy (range: 60.00–74.00) with median SD of 2.00 Gy (range: 1.80–2.00). For definitive RT, the pelvic lymph nodes (LNs) are treated in case of suspect findings in imaging (82.6%) and/or according to risk formulas/tables (78.0%). In the postoperative setting, 78.9% use imaging and 78.0% use the postoperative tumor stage for LN irradiation. In the definitive and postoperative situation, LNs are irradiated with a median EQD2(1.5 Gy) of 47.52 Gy with a range of 42.43–66.00 and 41.76–62.79, respectively. CONCLUSION: German-speaking radiation oncologists’ patterns of care for patients with PC are mainly in line with the published data and treatment recommendation guidelines. However, dose prescription is highly heterogenous for RT of the prostate/prostate bed, while the dose to the pelvic LNs is mainly consistent. SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00066-020-01738-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-8547211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-85472112021-10-29 Patterns of care for prostate cancer radiotherapy—results from a survey among German-speaking radiation oncologists Vogel, Marco M. E. Dewes, Sabrina Sage, Eva K. Devecka, Michal Gschwend, Jürgen E. Schiller, Kilian Combs, Stephanie E. Strahlenther Onkol Original Article BACKGROUND: Emerging moderately hypofractionated and ultra-hypofractionated schemes for radiotherapy (RT) of prostate cancer (PC) have resulted in various treatment options. The aim of this survey was to evaluate recent patterns of care of German-speaking radiation oncologists for RT of PC. METHODS: We developed an online survey which we distributed via e‑mail to all registered members of the German Society of Radiation Oncology (DEGRO). The survey was completed by 109 participants between March 3 and April 3, 2020. For evaluation of radiation dose, we used the equivalent dose at fractionation of 2 Gy with α/β = 1.5 Gy, equivalent dose (EQD2 [1.5 Gy]). RESULTS: Median EQD2(1.5 Gy) for definitive RT of the prostate is 77.60 Gy (range: 64.49–84.00) with median single doses (SD) of 2.00 Gy (range: 1.80–3.00), while for postoperative RT of the prostate bed, median EQD2(1.5 Gy) is 66.00 Gy (range: 60.00–74.00) with median SD of 2.00 Gy (range: 1.80–2.00). For definitive RT, the pelvic lymph nodes (LNs) are treated in case of suspect findings in imaging (82.6%) and/or according to risk formulas/tables (78.0%). In the postoperative setting, 78.9% use imaging and 78.0% use the postoperative tumor stage for LN irradiation. In the definitive and postoperative situation, LNs are irradiated with a median EQD2(1.5 Gy) of 47.52 Gy with a range of 42.43–66.00 and 41.76–62.79, respectively. CONCLUSION: German-speaking radiation oncologists’ patterns of care for patients with PC are mainly in line with the published data and treatment recommendation guidelines. However, dose prescription is highly heterogenous for RT of the prostate/prostate bed, while the dose to the pelvic LNs is mainly consistent. SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00066-020-01738-1) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2021-01-27 2021 /pmc/articles/PMC8547211/ /pubmed/33506347 http://dx.doi.org/10.1007/s00066-020-01738-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Vogel, Marco M. E. Dewes, Sabrina Sage, Eva K. Devecka, Michal Gschwend, Jürgen E. Schiller, Kilian Combs, Stephanie E. Patterns of care for prostate cancer radiotherapy—results from a survey among German-speaking radiation oncologists |
title | Patterns of care for prostate cancer radiotherapy—results from a survey among German-speaking radiation oncologists |
title_full | Patterns of care for prostate cancer radiotherapy—results from a survey among German-speaking radiation oncologists |
title_fullStr | Patterns of care for prostate cancer radiotherapy—results from a survey among German-speaking radiation oncologists |
title_full_unstemmed | Patterns of care for prostate cancer radiotherapy—results from a survey among German-speaking radiation oncologists |
title_short | Patterns of care for prostate cancer radiotherapy—results from a survey among German-speaking radiation oncologists |
title_sort | patterns of care for prostate cancer radiotherapy—results from a survey among german-speaking radiation oncologists |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547211/ https://www.ncbi.nlm.nih.gov/pubmed/33506347 http://dx.doi.org/10.1007/s00066-020-01738-1 |
work_keys_str_mv | AT vogelmarcome patternsofcareforprostatecancerradiotherapyresultsfromasurveyamonggermanspeakingradiationoncologists AT dewessabrina patternsofcareforprostatecancerradiotherapyresultsfromasurveyamonggermanspeakingradiationoncologists AT sageevak patternsofcareforprostatecancerradiotherapyresultsfromasurveyamonggermanspeakingradiationoncologists AT deveckamichal patternsofcareforprostatecancerradiotherapyresultsfromasurveyamonggermanspeakingradiationoncologists AT gschwendjurgene patternsofcareforprostatecancerradiotherapyresultsfromasurveyamonggermanspeakingradiationoncologists AT schillerkilian patternsofcareforprostatecancerradiotherapyresultsfromasurveyamonggermanspeakingradiationoncologists AT combsstephaniee patternsofcareforprostatecancerradiotherapyresultsfromasurveyamonggermanspeakingradiationoncologists |